Source comparison
CJC-1295 no DAC & Ipamorelin for Recovery: Application Comparison
Soft tissue injury (tendon, ligament) 100 mcg twice weekly (Days 1, 4) 200 mcg twice daily (morning, pre-sleep) 1.5–2× baseline by 48 hours, sustained 6–8 days Optimal for collagen synthesis—extended GH pulse duration increases fibroblast activity and Type I c
This comparison does not assign a generated winner or score.
- Soft tissue injury (tendon, ligament)
- 100 mcg twice weekly (Days 1, 4)
- 200 mcg twice daily (morning, pre-sleep)
- 1.5–2× baseline by 48 hours, sustained 6–8 days
- Optimal for collagen synthesis—extended GH pulse duration increases fibroblast activity and Type I collagen deposition
- Post-surgical wound healing
- 150 mcg twice weekly
- 250 mcg twice daily
- 1.8–2.2× baseline by 36 hours
- Accelerates epithelialization and granulation tissue formation—particularly effective in delayed-healing models
- Skeletal muscle repair (strain, contusion)
- 100 mcg twice weekly
- 300 mcg twice daily
- 1.6–2× baseline by 48 hours
- Enhances satellite cell proliferation and myofibril regeneration—most pronounced in Type II fiber repair
- Bone fracture healing
- 200 mcg twice weekly
- 200 mcg twice daily
- 2–2.5× baseline by 72 hours
- Stimulates osteoblast differentiation and mineralization—measurable callus formation improvement by 4–6 weeks
- Chronic inflammatory states (overuse)
- 200 mcg once daily (pre-sleep only)
- 1.4–1.8× baseline sustained
- Lower-frequency Ipamorelin dosing prevents cortisol rebound while maintaining anti-inflammatory IGF-1 signaling
- The table clarifies application-specific dosing adjustments. Bone healing benefits from higher CJC-1295 no DAC doses (200 mcg) due to the extended IGF-1 elevation required for osteoblast activity, while chronic inflammatory models respond better to conservative Ipamorelin frequency to avoid paradoxical cortisol elevation from excessive GH pulsatility.